Anavex Life Sciences
AVXL
#7722
Rank
C$0.49 B
Marketcap
C$5.54
Share price
1.52%
Change (1 day)
-70.53%
Change (1 year)

EPS for Anavex Life Sciences (AVXL)

EPS in 2025 (TTM): C-$0.76

According to Anavex Life Sciences 's latest financial reports the company's current EPS (TTM) is C-$0.75. In 2024 the company made an earnings per share (EPS) of C-$0.72 an increase over its 2023 EPS that were of C-$0.83.

EPS history for Anavex Life Sciences from 2004 to 2025

Annual EPS

Year EPS Change
2025 (TTM)C-$0.765.63%
2024C-$0.72-13.33%
2023C-$0.83-3.23%
2022C-$0.8614.81%
2021C-$0.7520%
2020C-$0.62-16.67%
2019C-$0.7538.46%
2018C-$0.5418.18%
2017C-$0.46-21.43%
2016C-$0.58-35.38%
2015C-$0.90-36.27%
2014C-$1.41112.5%
2013C-$0.66-58.62%
2012C-$1.60-0%
2011C-$1.60-29.27%
2010C-$2.2751.85%
2009C-$1.49-0%
2008C-$1.49237.5%
2007C-$0.44
2006N/A-100%
2005C-$0.05526499.97%
2004C-$0.009210

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Ligand Pharmaceuticals
LGND
C$3.30-542.59%๐Ÿ‡บ๐Ÿ‡ธ USA
BioCryst Pharmaceuticals
BCRX
C-$0.06907-90.74%๐Ÿ‡บ๐Ÿ‡ธ USA
Corcept Therapeutics
CORT
C$1.38-285.19%๐Ÿ‡บ๐Ÿ‡ธ USA
Palatin Technologies
PTN
C-$41.30 5,437.04%๐Ÿ‡บ๐Ÿ‡ธ USA